Aphria Inc (TSX:APHA)(NYSE:APHA) has been a surprise winner in an otherwise terrible summer for marijuana stocks, rising more than 20% after a Q4 earnings beat. The company’s financial results and its rising share price distinguish it from other marijuana stocks, which have been getting hit thanks to a combination of negative earnings and increased regulatory scrutiny. In Q4, Aphria posted results…
Read More
Last week was a rough one for Canopy Growth Corp (TSX:WEED)(NYSE:CGC). The stock had already been struggling in recent months and after the company released its first-quarter results, the stock fell even further, falling below $40 a share for the first time since January. At over $37 to finish the week, Canopy Growth is right around its 52-week low and there’s the…
Read More
Cannabis investors have had a rough ride in the last 12 months. Several stocks lost significant value due to regulatory issues and missing analyst target estimates. Cannabis stocks were overvalued and expensive. Shares of Cronos Group (TSX:CRON)(NASDAQ:CRON) have fallen 46% since March 2019. Despite the recent pullback, the stock has returned a mind-blowing 1,825% since its IPO back in December…
Read More
After Aphria announced its financial earnings for the 2019 fiscal year this month, you might have been curious about the performance of CannTrust (TSX:TRST)(NYSE:CTST). Unfortunately, you will be bitterly disappointed by the company after it started to face problems with regulators and its stock plummeted. What happened with CannTrust? The dominoes began to fall when CannTrust applied for a management…
Read More
Last week was not a good one for Canopy Growth Corporation (TSX:WEED)(NYSE:CGC). After some of its competitors announced solid earnings — including a few who told investors they were profitable — Canopy Growth disappointed the market when it announced adjusted EBITDA of negative $92 million. That came on net revenue of just over $90 million, which was lower than analysts…
Read More
Things just keep getting uglier for cannabis stocks. Following a brief uplift, CannTrust Holdings (TSX:TRST)(NYSE:CTST) resumed its tumble on news that Health Canada had found even more unlicensed grow sites. CannTrust shares have fallen about 56% since the scandal began, while other marijuana stocks are being hit hard as well, whether due to regulatory concerns or growing losses. In the midst…
Read More
It’s been a wild ride for cannabis investors so far this summer, and not like in the summer of 2018. Whereas last year, there were the super highs from investors excited about the new industry, after several ups and downs, investors have become a lot more wary of where stocks are headed. With some cannabis stocks reporting profits and others…
Read More
While cannabis stocks have not performed well since early April, the month of July was especially brutal for the sector. There is no doubt that the drama surrounding CannTrust Holdings (TSX:TRST)(NYSE:CRST) had a lot to do with this catastrophic performance. However, there may be a silver lining — or at least an important lesson to glean — from this scandal,…
Read More
High insider ownership is usually considered a good sign for a stock’s future prospects. When people who know everything about a company’s operations buy it, it indicates that the stock has a good future — or so the theory goes. Enter Canopy Growth (TSX:WEED)(NYSE:CGC). Recently, it was revealed that the company’s ex-CEO Bruce Linton had been buying up shares, calling its…
Read More
Cannabis stocks were riding high, as we moved into the spring of 2019. The glow had returned after a rough post-legalization dip for the sector. Broader market turbulence has historically had a strong impact on cannabis stocks, and the late 2018 correction was no different. Unfortunately, this momentum has not lasted. In the middle of spring, I’d warned investors that…
Read More